Obesity at the Limits

Written by David Jones

Jan 23, 2024

January 23, 2024

5 continents, 2 days, 1 global event



Our biggest new event for some years is now well into development and we’re pleased to announce that Obesity at the Limits will join our roster of meetings in 2025.

We’ve started early as the initiative is something quite major and it’s going to take a lot of planning to expertly run five international meetings across the globe across the same two days in March next year: the 4th & 5th March, selected to coincide with World Obesity Day.


Chairs & Faculty

The lead chairs hosting the meeting in the UK will be Professor John Wilding of the University of Liverpool, and Professor Derek Yellon, the Director of the Hatter Cardiovascular Institute at UCL. Between them they have selected a faculty of internationally renowned speakers to address the events and to discuss multiple aspects of obesity management including scientific, social and financial challenges.

Across the globe in North and South America, Africa/Middle East and Asia Pac our regional chairs will have the option of streaming presentations from other events, or inviting presenters from their region to address delegates live at the event venue. We’ll also leave it to them to choose the final venue based on the needs and expectation of their audiences particularly relating to inequities of treatment based on wealth and ethnic disparities.


Carbon footprint

And we’ll be massively cutting the carbon footprint of the events by requiring any long-haul speakers to stream their presentations to other meetings… only regional (short haul) travel will be funded to attend the meetings. If we achieve the maximum possible savings, we can cut the carbon emissions directly linked to travel by almost 95%, an exceptional saving made even better by the fact that we will then invest in carbon offset schemes to create a 100% carbon neutral travel footprint.


Built from the ground up for delegates and funders

The meetings have been specifically designed to meet the needs of our delegates, and of our funders from the pharmaceutical, device and other associated obesity industries. With over 25 years of feedback from our other events we can accurately predict the expectations of delegates around the balance of education, discussion, debate and networking. And for our funders we can create environments where they can connect with healthcare professionals to build the relationships which are key to the development of future treatment.


The Lancet Diabetes & Endocrinology Commission on Obesity

Finally, we’ll feature exclusive content created by our colleagues at The Lancet Diabetes and Endocrinology relating to their commission on obesity which is scheduled for release in 2024. The launch of the commission and its associated reports are sure to be high-profile activities and we’re pleased to be associated with this landmark publication.

We’ll release details of the events in the next few months so remember to check the blog for updates!

Related Articles

The Malvern Diabetic Foot Conference

The Malvern Diabetic Foot Conference

Every two years, in May, we have the privilege of running the Malvern Diabetic Foot meeting. The 2024 conference last month was the 20th meeting since its inception in 1986, and over three days engaged physicians, surgeons, podiatrists, orthotists, nursing staff and...

AI in Healthcare – Dr Google will see you now

AI in Healthcare – Dr Google will see you now

'One of the key tenets of At the Limits has been to provide medical education to the widest possible audience, irrespective of global location or wealth. It’s a way in which we can contribute to the democratisation of healthcare. And that’s something that will become...

Seasons Greetings, Merry Christmas and a Happy New Year

Seasons Greetings, Merry Christmas and a Happy New Year

Two subjects this month, a quick revisit to the VPAS situation and our plans for 2024. VPAS … again The new VPAS scheme was agreed at the end of November, and although the ABPI and Pharma Industry publicly support the deal it’s difficult to realistically see it as the...